IL6 and triple-negative breast carcinoma: MIR100HG promotes the proliferation of nasopharyngeal carcinoma cells via the miR-136-5p/IL-6 axis (84) and enhances the growth of triple-negative breast cancer cells through the miR-5590-3p/OTX1 axis (85).